Japan
· Delayed Price · Currency is JPY SUSMED,Inc. Statistics
Total Valuation
SUSMED,Inc. has a market cap or net worth of JPY 9.36 billion. The enterprise value is 4.81 billion.
| Market Cap | 9.36B |
| Enterprise Value | 4.81B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SUSMED,Inc. has 16.81 million shares outstanding. The number of shares has increased by 1.05% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 16.81M |
| Shares Change (YoY) | +1.05% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 43.25% |
| Owned by Institutions (%) | 18.26% |
| Float | 7.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.43 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.30 |
| EV / Sales | 32.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.07 |
Financial Position
The company has a current ratio of 13.66
| Current Ratio | 13.66 |
| Quick Ratio | 13.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.62% and return on invested capital (ROIC) is -7.85%.
| Return on Equity (ROE) | -12.62% |
| Return on Assets (ROA) | -7.31% |
| Return on Invested Capital (ROIC) | -7.85% |
| Return on Capital Employed (ROCE) | -13.26% |
| Revenue Per Employee | 3.85M |
| Profits Per Employee | -14.85M |
| Employee Count | 39 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 1.43 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 565.82 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.98 |
| Average Volume (20 Days) | 83,770 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SUSMED,Inc. had revenue of JPY 150.00 million and -579.00 million in losses. Loss per share was -34.56.
| Revenue | 150.00M |
| Gross Profit | 137.00M |
| Operating Income | -576.00M |
| Pretax Income | -578.00M |
| Net Income | -579.00M |
| EBITDA | -571.00M |
| EBIT | -576.00M |
| Loss Per Share | -34.56 |
Balance Sheet
The company has 4.56 billion in cash and n/a in debt, giving a net cash position of 4.56 billion or 271.04 per share.
| Cash & Cash Equivalents | 4.56B |
| Total Debt | n/a |
| Net Cash | 4.56B |
| Net Cash Per Share | 271.04 |
| Equity (Book Value) | 4.34B |
| Book Value Per Share | 258.25 |
| Working Capital | 4.29B |
Cash Flow
In the last 12 months, operating cash flow was -526.00 million and capital expenditures -4.00 million, giving a free cash flow of -530.00 million.
| Operating Cash Flow | -526.00M |
| Capital Expenditures | -4.00M |
| Free Cash Flow | -530.00M |
| FCF Per Share | -31.52 |
Margins
| Gross Margin | 91.33% |
| Operating Margin | -384.00% |
| Pretax Margin | -385.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SUSMED,Inc. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.05% |
| Shareholder Yield | -1.05% |
| Earnings Yield | -6.18% |
| FCF Yield | -5.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUSMED,Inc. has an Altman Z-Score of 17.63.
| Altman Z-Score | 17.63 |
| Piotroski F-Score | n/a |